Proteomics

Dataset Information

0

Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment


ABSTRACT: Aims: Despite the high prevalence of heart failure with preserved ejection fraction (HFpEF), the pathomechanisms remain elusive and specific therapy is lacking. Disease-causing factors include metabolic risk, notably obesity. However, proteomic changes in HFpEF are poorly understood, hampering therapeutic strategies. We sought to elucidate how metabolic syndrome affects cardiac protein expression, phosphorylation and acetylation in the Zucker diabetic fatty/Spontaneously hypertensive heart failure F1 (ZSF1) rat HFpEF model, and to evaluate some changes regarding their potential for treatment. Main methods: ZSF1 obese and lean rats were fed a Purina diet up to the onset of HFpEF in the obese animals. We quantified the proteome, phosphoproteome and acetylome of ZSF1 obese versus lean heart tissues by mass spectrometry and singled out targets for site-specific evaluation. Key findings: We found the acetylome of ZSF1 obese versus lean hearts more severely altered (21% of proteins changed) than the phosphoproteome (9%) or proteome (3%). Proteomic alterations, confirmed by immunoblotting, indicated low-grade systemic inflammation and endothelial remodeling in obese hearts, but low nitric oxide-dependent oxidative/nitrosative stress. Altered acetylation in ZSF1 obese hearts mainly affected pathways important for metabolism, energy production and mechanical function, including hypo-acetylation of mechanical proteins but hyper-acetylation of proteins regulating fatty acid metabolism. Hypo-acetylation and hypo-phosphorylation of elastic titin in ZSF1 obese hearts explained myocardial stiffening. Significance: Cardiometabolic syndrome alters posttranslational modifications, notably acetylation, in experimental HFpEF. Pathway changes implicate a HFpEF signature of low-grade inflammation, endothelial dysfunction, metabolic and mechanical impairment, and suggest titin stiffness and mitochondrial metabolism as promising therapeutic targets.

INSTRUMENT(S): Q Exactive Plus

ORGANISM(S): Rattus Norvegicus (rat)

TISSUE(S): Heart

SUBMITTER: Franziska Koser  

LAB HEAD: Wolfgang A. Linke

PROVIDER: PXD036259 | Pride | 2022-10-12

REPOSITORIES: Pride

altmetric image

Publications

Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.

Koser Franziska F   Hobbach Anastasia J AJ   Abdellatif Mahmoud M   Herbst Viktoria V   Türk Clara C   Reinecke Holger H   Krüger Marcus M   Sedej Simon S   Linke Wolfgang A WA  

Life sciences 20220927


<h4>Aims</h4>Despite the high prevalence of heart failure with preserved ejection fraction (HFpEF), the pathomechanisms remain elusive and specific therapy is lacking. Disease-causing factors include metabolic risk, notably obesity. However, proteomic changes in HFpEF are poorly understood, hampering therapeutic strategies. We sought to elucidate how metabolic syndrome affects cardiac protein expression, phosphorylation and acetylation in the Zucker diabetic fatty/Spontaneously hypertensive hear  ...[more]

Similar Datasets

2014-06-18 | E-GEOD-58576 | biostudies-arrayexpress
2014-06-18 | E-GEOD-58575 | biostudies-arrayexpress
2022-02-23 | PXD020204 | Pride
2023-06-02 | PXD029715 | Pride
2017-05-15 | E-GEOD-68885 | biostudies-arrayexpress
2015-03-03 | E-GEOD-50574 | biostudies-arrayexpress
2013-06-12 | E-GEOD-47414 | biostudies-arrayexpress
2013-12-18 | E-GEOD-53403 | biostudies-arrayexpress
2021-09-09 | PXD023354 | Pride
2018-12-12 | E-MTAB-6728 | biostudies-arrayexpress